Glass House Brands (GLAS) Invested Capital (2020 - 2025)
Glass House Brands' (GLAS) quarterly Invested Capital came in at $1.9 million in Q4 2025, down 25.42% year-on-year from $2.6 million in Q4 2024, and down 25.42% on a QoQ basis from $2.6 million in Q4 2024.
Glass House Brands (GLAS) Invested Capital (2020 - 2025) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Invested Capital data on file, last reported at $1.9 million in Q4 2025.
- On a quarterly basis, Invested Capital fell 25.42% year-over-year to $1.9 million in Q4 2025; TTM through Mar 2026 was $1.9 million, a 25.42% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 25.42% from the prior year.
- Invested Capital for Q4 2025 stood at $1.9 million, down from $2.6 million in the prior quarter.
- Over the last five years, Invested Capital for GLAS reached as high as $4.6 million in Q1 2021 and fell as low as $1.9 million in Q4 2025.
- Historically, Invested Capital has averaged $3.0 million across 3 years, with a median of $2.6 million in 2024.
- On a YoY basis, Invested Capital climbed as much as 25.42% in 2025 and fell as far as 25.42% in 2025.
- Year by year, Invested Capital stood at $4.6 million in 2021, then tumbled by 44.06% to $2.6 million in 2024, then decreased by 25.42% to $1.9 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $1.9 million in Q4 2025, $2.6 million in Q4 2024, and $4.6 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 14.77 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Mar 31, 2021 | 4.61 Mn |
| Dec 31, 2020 | 349,034.00 |